Journal of Antivirals & Antiretrovirals
Open Access

Department of Infectious Disease and Clinical Microbiology, Erzincan Binali Yıldırım University, Erzincan, Turkey

Biography

Ozlem Gul works at Department of Infectious Disease and Clinical Microbiology, Erzincan Binali Y?ld?r?m University, Erzincan, Turkey. His area of research interests includes Virology Infectious diseases and clinical microbiology. He has authored of many research articles/books in relevant areas. 

Publications

• Research Article   
  Level of SARS-CoV-2 IgG Antibodies after Two Doses CoronaVac Vaccine: Primarily Report
  Author(s): Umut Devrim Binay*, Faruk Karakecili, Orcun Barkay, Ozlem Gul and Cuma Mertoglu
  
  Background: It is necessary to use an effective vaccine to end the COVID-19 pandemic. CoronaVac vaccine is used in our country and we aimed to examine the level of antibody development after the second dose. Methods: This is a retrospective, cross-sectional research. The data of the people, who applied to a university hospital between January and March 2021, were analyzed. Those who had SARS-CoV-2 IgG and IgM measurement in the previous two weeks before the CoronoVac vaccine, and those who were both found negative and who had SARS-CoV- 2 IgG and IgM measurement after the second dose of CoronaVac vaccine were included in the research. SARS-CoV-2 IgG/IgM were measured by VIDAS® (BioMérieux, Marcy-l'Etoile, France) device for the detection of spike protein specific IgG/IgM of SARS-CoV-2 in human serum with .. View More»
  DOI: 10.35248/1948-5964.21.s18.005

  Abstract HTML PDF